Biotechnology

Bristol-Myers Squibb to Buy Padlock

GSK and Miltenyi Biotec in Cell and Gene Therapy Pact

Blueprint and Roche in Cancer Immunotherapy Deal

GSK Ends Cancer Deal With Five Prime

Patheon and Amgen in Toll Manufacturing Pact

Sanofi Seals two Oncology Partnerships

Industrial Biotech Firm Brain Plans IPO

AstraZeneca Confirms Talks with Acerta

CDT to Commercialize Veterinary Cancer Drug

Korean Drug Specialists Collaborate on Cancer Therapy

DuPont to Buy Dyadic Biotech Assets

Shire to Buy Biotech Firm Dyax

Topics • Technology

Quality and Reliability

Topics • Technology

Bavaria’s “Region of Renewable Raw Materials”

Topics • Strategy

Biohybrid Chemistry Cluster

Biogen to Cut Staff, Focus on Oral MS Drug

Topics • Technology

Innovative Medicine with Rising Productivity Targets

Topics • Strategy

Leaving the Patent Cliff Behind

Bavarian Nordic Wins Janssen Ebola Subcontract

Amgen to Buy Dezima Pharma, Collaborates with Xencor

Topics • Strategy

Significant Value Creation

United Therapeutics Sells Priority Review Voucher to AbbVie

Topics • Logistics

Pharmaserv Logistics Now with a New Website

Topics • Logistics

Pharmaserv Logistics Creates a "Central Pharmaceutical Distribution Center"

New Scottish Plant Doubles BioOutsource Capacity

Topics • Chemistry

Bio-Based Economy in Europe: Potential Benefits and Risks

Celgene Offers $7.2 Billion for Receptos

Topics • Strategy

Enriching the Microbiome

Alexion Paying $8.4 Billion to Acquire Synageva

Topics • Chemistry

Reinventing Sustainable Value Creation

DuPont to Buy Microbials Specialist Taxon Biosciences

Bayer to Build Hemophilia A New Testing Facility in California

Arvinas Collaborates with Merck & Co. on Novel Therapeutics

Fujifilm Holdings to Acquire Cellular Dynamics

AbbVie and Puerto Rico Announce $30 Million Expansion

241 more articles

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Interview

Navigating Uncertainty and Driving Innovation

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Tufts University

Bio Consortia

Henkel AG & Co. KGaA

BioCampus Straubing

Dottikon Exclusive Synthesis AG

Kaye Scholer

Novozymes Biopharma UK Ltd.

Ontario Int. Marketing Ct.

Thomson Reuters

PhytoAR Biotechnologie GmbH

AstraZeneca

Olon S.p.A.

Messe München GmbH

Rentschler Biopharma SE

ACIB Austrian Centre of Industrial Biotechnology

Millipore Corporation

GEA Liquid Processing

Groupe Novasep

Alira Health S.r.l.

European Circular Bioeconomy Fund (ECBF)

Bio4Business

Wacker Chemie

Germany Trade & Invest

Jennewein Biotechnologie GmbH

SchüllerConsulting

Farmindustria

CzechInvest

AbbVie Inc.

Sartorius AG

BCNP Consultants GmbH

Arthur D. Little

Primogene GmbH

Evonik Industries AG

Federchimica